[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100146616":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":23,"locations":32,"responsibleParty":98,"collaborators":100,"id":105,"slug":106,"hasResults":107,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":111,"eligibilityCriteria":112,"healthyVolunteers":107,"sex":113,"minAge":114,"maxAge":10,"enrollmentInfo":115,"targetDuration":10,"studyType":118,"phases":10,"briefSummary":119,"conditions":120,"keywords":122,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":137},{"fullName":5,"class":6},"Insel Gruppe AG, University Hospital Bern","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"1",null,"Patients with type 1 or type 2 diabetes mellitus, monogenetic diabetes, pancreatogenic diabetes, drug-induced diabetes, other forms",[13,17,20],{"name":14,"affiliation":15,"role":16},"Michael Brändle, Prof.","Div. of Endocrinology, Diabetes and Clinical Nutrition, Kantonsspital St. Gallen","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":19,"role":16},"Markus Laimer, PD Dr. med.","Div. of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Bern",{"name":21,"affiliation":22,"role":16},"Roger Lehmann, Prof.","Div. of Endocrinology, Diabetes and Clin. Nutrition, University Hospital Zürich",[24,28],{"name":18,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","+41 31 632 30 62","Markus.Laimer@insel.ch",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},"Christoph Stettler, Prof.","+41 31 632 40 70","christoph.stettler@insel.ch",[33,55,66,80],{"facility":34,"status":35,"city":36,"state":10,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern","RECRUITING","Bern","3010","Switzerland","CH",{"type":41,"coordinates":42},"Point",[43,44],7.44744,46.94809,{"lat":44,"lon":43},[47,48,49,50,53],{"name":18,"role":25,"phone":26,"phoneExt":10,"email":27},{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},{"name":18,"role":16,"phone":10,"phoneExt":10,"email":10},{"name":51,"role":52,"phone":10,"phoneExt":10,"email":10},"Peter Diem, Prof.","SUB_INVESTIGATOR",{"name":54,"role":52,"phone":10,"phoneExt":10,"email":10},"Katja Müller-Fischer, Dr. med.",{"facility":56,"status":35,"city":57,"state":10,"zip":10,"country":38,"countryCode":39,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Service d'endocrinologie, diabétologie et métabolisme","Lausanne",{"type":41,"coordinates":59},[60,61],6.63282,46.516,{"lat":61,"lon":60},[64],{"name":65,"role":25,"phone":10,"phoneExt":10,"email":10},"Valerie Schwitzgebel",{"facility":67,"status":35,"city":68,"state":10,"zip":69,"country":38,"countryCode":39,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen","Sankt Gallen","9007",{"type":41,"coordinates":71},[72,73],9.37477,47.42391,{"lat":73,"lon":72},[76,78],{"name":77,"role":16,"phone":10,"phoneExt":10,"email":10},"Michael Brändle, Prof. Dr. med., M.Sc.",{"name":79,"role":52,"phone":10,"phoneExt":10,"email":10},"Katrin Schimke, Dr. med.",{"facility":81,"status":35,"city":82,"state":10,"zip":83,"country":38,"countryCode":39,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich","Zurich","8091",{"type":41,"coordinates":85},[86,87],8.55,47.36667,{"lat":87,"lon":86},[90,92,94,96],{"name":91,"role":16,"phone":10,"phoneExt":10,"email":10},"Roger Lehmann, Prof. Dr. med.",{"name":93,"role":52,"phone":10,"phoneExt":10,"email":10},"Jan Krützfeld, Prof. Dr. med.",{"name":95,"role":52,"phone":10,"phoneExt":10,"email":10},"Giatgen Spinas, Prof. Dr. med.",{"name":97,"role":52,"phone":10,"phoneExt":10,"email":10},"Philipp Gerber, PD Dr. med.",{"type":99,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[101,103],{"name":102,"class":6},"Cantonal Hospital of St. Gallen",{"name":104,"class":6},"University of Zurich","100146616","swiss-diabetes-registry---swissdiab-study-100146616",false,"NCT01179815","Swiss Diabetes Registry - SwissDiab Study","Swiss Diabetes Registry - SwissDiab Study, a Prospective Cohort Study of Patients With Diabetes in Switzerland","SwissDiab","Inclusion Criteria:\n\n* Age \\> 18 years\n* Diagnosis of diabetes mellitus according to ADA criteria\n* Informed consent\n\nExclusion Criteria:\n\n* Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (\\\u003C1 year) will be excluded","ALL","18 Years",{"count":116,"type":117},1500,"ESTIMATED","OBSERVATIONAL","Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries.\n\nFor Switzerland only sparse data exist on the actual implementation of such recommendations and on patient's well-being. The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study aiming at including and collecting data of virtually all patients regularly seen and treated at the study centers (≈ 500 patients each), irrespective of type, duration of diabetes or treatment . This allows the evaluation of diabetes treatment strategies at these centers. Furthermore, risk indicators for micro- and macrovascular complications, mortality as well as costs and quality of life will be assessed. Data will be recorded through an internet-based, electronic database specifically designed for this study. At a later perspective it is planned to extend data collection to general practitioner\u002Ffamily doctor networks in order to include a larger and more representative sample of patients with diabetes in Switzerland.",[121],"Diabetes Mellitus",[123,124,125,126,127],"Patients with type 1 or type 2 diabetes mellitus","Monogenetic diabetes","Pancreatogenic diabetes,","Drug-induced diabetes, other forms","Cohort Studies","2026-06-08",{"date":130,"type":131},"2026-06-11","ACTUAL",{"date":133,"type":10},"2010-01",{"date":135,"type":117},"2099-01",{"name":5,"class":6},4]